Factors in improved survival from paediatric cancer

被引：6

作者：

Taub, JW ^{[1
]}

机构：

[1] Wayne State Univ, Div Hematol Oncol, Childrens Hosp Michigan, Sch Med,Barbara Ann Karmanos Canc Inst, Detroit, MI 48201 USA

来源：

DRUGS | 1998年 / 56卷 / 05期

关键词：

D O I：

10.2165/00003495-199856050-00002

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

In 1998, over two-thirds of children diagnosed with cancer will be cured of their disease. This has been accomplished by improvements in understanding the biology of the various forms of cancer and stratifying protocol-based therapies (surgery, radiotherapy and chemotherapy) based on predicted treatment outcome and risk of treatment failure. The excellent prognosis of subgroups of malignancies, including acute lymphoblastic leukaemia, Hodgkin's disease, non-Hodgkin's lymphoma and Wilms' tumour, has led to the modification of therapies to decrease or minimise long term adverse effects which may have a significant impact on the quality of life of survivors. The lessons learned from the treatment of paediatric cancer may lead to improvements in the treatment of adult cancers.

引用

页码：757 / 765

页数：9

共 92 条

[11]

Bloomfield CD, 1998, CANCER RES, V58, P4173

[12] INCIDENCE OF 2ND CANCERS IN PATIENTS TREATED FOR HODGKINS-DISEASE [J].

BOIVIN, JF ;

HUTCHISON, GB ;

ZAUBER, AG ;

BERNSTEIN, L ;

DAVIS, FG ;

MICHEL, RP ;

ZANKE, B ;

TAN, CTC ;

FULLER, LM ;

MAUCH, P ;

ULTMANN, JE .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (10) :732-741

[13] Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: A pediatric oncology group study [J].

Bowman, WP ;

Shuster, JJ ;

Cook, B ;

Griffin, T ;

Behm, F ;

Pullen, J ;

Link, M ;

Head, D ;

Carroll, A ;

Berard, C ;

Murphy, S .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (04) :1252-1261

[14] CLINICAL EVALUATION OF A NEW ANTIMETABOLITE, 6-MERCAPTOPURINE, IN THE TREATMENT OF LEUKEMIA AND ALLIED DISEASES [J].

BURCHENAL, JH ;

MURPHY, ML ;

ELLISON, RR ;

SYKES, MP ;

TAN, TC ;

LEONE, LA ;

KARNOFSKY, DA ;

CRAVER, LF ;

DARGEON, HW ;

RHOADS, CP .

BLOOD, 1953, 8 (11) :965-999

[15] Genetic disease in offspring of long-term survivors of childhood and adolescent cancer [J].

Byrne, J ;

Rasmussen, SA ;

Steinhorn, SC ;

Connelly, RR ;

Myers, MH ;

Lynch, CF ;

Flannery, J ;

Austin, DF ;

Holmes, FF ;

Holmes, GE ;

Strong, LC ;

Mulvihill, JJ .

AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (01) :45-52

[16] Biology and treatment of neuroblastoma [J].

Castleberry, RP .

PEDIATRIC CLINICS OF NORTH AMERICA, 1997, 44 (04) :919-&

[17] Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia [J].

Cavé, H ;

ten Bosch, JV ;

Suciu, S ;

Guidal, C ;

Waterkeyn, C ;

Otten, J ;

Bakkus, M ;

Thielemans, K ;

Grandchamp, B ;

Vilmer, E .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (09) :591-598

[18] CENTRAL-NERVOUS-SYSTEM DIRECTED THERAPY IN ACUTE LYMPHOBLASTIC-LEUKEMIA [J].

CHESSELLS, JM .

BAILLIERES CLINICAL HAEMATOLOGY, 1994, 7 (02) :349-363

[19]

Culver KW, 1996, BONE MARROW TRANSPL, V18, pS6

[20] CURABILITY OF ADVANCED HODGKINS-DISEASE WITH CHEMOTHERAPY [J].

DEVITA, VT ;

SIMON, RM ;

HUBBARD, SM ;

YOUNG, RC ;

BERARD, CW ;

MOXLEY, JH ;

FREI, E ;

CARBONE, PP ;

CANELLOS, GP .

ANNALS OF INTERNAL MEDICINE, 1980, 92 (05) :587-595

← 1 2 3 4 5 6 7 8 9 10 →